MacKay M, et al.The therapeutic landscape for cells engineered with chimeric antigen receptors.Nat Biotechnol. 2020 Feb;38(2):233-244.
Cho, J. H., Collins, J. J. & Wong, W. W. Universal chimeric antigen
receptors for multiplexed and logical control of T cell responses. Cell 173,
1426–1438.e11 (2018).
Garrett-Bakelman, F. E. et al. Te NASA Twins Study: a multi-omic,
molecular, physiological, and behavioral analysis of a year-long human
spacefight. Science 364, eaau8650 (2019).
Victor Moreno et al,Adoptive cell therapy for solid tumors:Chimeric antigen receptor T cells and beyond,CurrentOpinion in Pharmacology 2021, 59:70–84
.Shimizu Y, Suzuki T, YoshikawaT, Endo I and Nakatsura T (2019) Next-Generation Cancer Immunotherapy TargetingGlypican-3. Front. Oncol. 9:248
DonghuaShi et al,ChimericAntigen Receptor-Glypican-3 T-Cell Therapy for Advanced HepatocellularCarcinoma: Results of Phase I Trials,Clin Cancer Res .2020 Aug 1;26(15):3979-3989.
StevenC. Katz et al,HITM-SIR:phase Ib trial of intraarterial chimeric antigen receptor T-cell therapy andselective internal radiation therapy for CEA+ liver metastases,Cancer Gene Therapy https://doi.org/10.1038/s41417-019-0104-z
ChengchengZhang et al,Phase IEscalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic ColorectalCancers, Molecular Therapy Vol. 25 No 5 May 2017
ChristopherC. Kloss et al,Dominant-NegativeTGF-b Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation AndAugments Prostate Cancer Eradication,Molecular TherapyVol. 26 No 7 July 2018
YajunZhang et al,Phase Iclinical trial of EGFR‑specifcCAR‑T cells generated by thepiggyBac transposon system in advanced relapsed/refractory non‑small cell lung cancer patients,Journal of Cancer Researchand Clinical Oncology https://doi.org/10.1007/s00432-021-03613-7YangLiu et al,Anti-EGFRchimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma:A phase I clinical trial,Cytotherapy 22 (2020) 573-580